Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 7, 2013 - Issue
Submit an article Journal homepage
105
Views
23
CrossRef citations to date
0
Altmetric
Review

Profile of certolizumab and its potential in the treatment of psoriatic arthritis

Maria Sole Chimenti1 Unit of Rheumatology, Allergology, and Clinical Immunology, University of Rome Tor Vergata, Rome, ItalyCorrespondence[email protected]
,
Rosita Saraceno2 Unit of Dermatology, University of Rome Tor Vergata, Rome, Italy
,
Andrea Chiricozzi2 Unit of Dermatology, University of Rome Tor Vergata, Rome, Italy;3 Laboratory for Investigative Dermatology, Rockefeller University, New York, NY, USA
,
Alessandro Giunta2 Unit of Dermatology, University of Rome Tor Vergata, Rome, Italy
,
Sergio Chimenti2 Unit of Dermatology, University of Rome Tor Vergata, Rome, Italy
&
Roberto Perricone1 Unit of Rheumatology, Allergology, and Clinical Immunology, University of Rome Tor Vergata, Rome, Italy
Pages 339-348 | Published online: 15 Apr 2013

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Maria Sole Chimenti, Arianna D’Antonio, Paola Conigliaro, Sara Ferrigno, Andrea Vendola, Mario Ferraioli, Paola Triggianese, Luisa Costa, Francesco Caso & Roberto Perricone. (2020) An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis. Biologics: Targets and Therapy 14, pages 53-75.
Read now
Francesco Caso, Maria Sole Chimenti, Luca Navarini, Piero Ruscitti, Rosario Peluso, Nicolò Girolimetto, Antonio Del Puente, Roberto Giacomelli, Raffaele Scarpa & Luisa Costa. (2020) Metabolic Syndrome and psoriatic arthritis: considerations for the clinician. Expert Review of Clinical Immunology 16:4, pages 409-420.
Read now
Anna Campanati, Matteo Paolinelli, Frederico Diotallevi, Emanuela Martina, Elisa Molinelli & Annamaria Offidani. (2019) Pharmacodynamics OF TNF α inhibitors for the treatment of psoriasis. Expert Opinion on Drug Metabolism & Toxicology 15:11, pages 913-925.
Read now
Alfredo Adán, Aina Moll-Udina, Carmen Alba-Linero, Juan Pablo Figueroa-Vercellino & Victor Llorenç. (2019) Recent progress in the treatment of uveitic macular edema. Expert Review of Ophthalmology 14:4-5, pages 227-236.
Read now
Takayuki Hoshiyama, Yu Matsueda, Toshihiro Tono, Yoshiyuki Arinuma, Tatsuo Nagai & Shunsei Hirohata. (2018) Differential influences of Fc gamma receptor blocking on the effects of certolizumab pegol and infliximab on human monocytes. Modern Rheumatology 28:3, pages 506-512.
Read now
María Laura Acosta-Felquer, Javier Rosa & Enrique R Soriano. (2016) An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy. Open Access Rheumatology: Research and Reviews 8, pages 37-44.
Read now
Andrea Matucci, Daniele Cammelli, Fabrizio Cantini, Delia Goletti, Valentina Marino, Giuseppe Maria Milano, Raffaele Scarpa, Giuliano Tocci, Enrico Maggi & Alessandra Vultaggio. (2016) Influence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative review. Expert Opinion on Drug Safety 15:sup1, pages 3-10.
Read now

Articles from other publishers (16)

Anaïs Makos, J. H. Kuiper, O. Kehoe & R. Amarasena. (2022) Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors. Inflammopharmacology 31:1, pages 77-87.
Crossref
Annunziata DATTOLA, Laura VOLLONO, Maria V. CANNIZZARO, Raffaele D. CAPOSIENA CARO, Sara MAZZILLI, Gennaro MELINO, Eleonora CANDI, Elena CAMPIONE & Luca BIANCHI. (2021) Efficacy of certolizumab pegol in naïve versus multi-treated patients affected by psoriatic arthritis. Italian Journal of Dermatology and Venereology 156:4.
Crossref
Mona Sadeghalvad & Nima Rezaei. 2021. Monoclonal Antibodies. Monoclonal Antibodies.
Robert Gironés Petit, Amanda Cano, Alba Ortiz, Marta Espina, Josefina Prat, Montserrat Muñoz, Patrícia Severino, Eliana B. Souto, Maria L. García, Montserrat Pujol & Elena Sánchez-López. (2021) Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics. International Journal of Molecular Sciences 22:9, pages 4983.
Crossref
Maria Sole Chimenti, Paola Conigliaro, Livia Biancone & Roberto Perricone. (2021) Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2097777.
Crossref
Olga Yu. Olisova & Ekaterina M. Anpilogova. (2020) Systemic treatment of psoriasis: from methotrexate to biologics. Vestnik dermatologii i venerologii 96:3, pages 7-26.
Crossref
Alan Menter, Bruce E. Strober, Daniel H. Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena N. Rupani, Michael Siegel, Emily B. Wong, Jashin J. Wu, Vidhya Hariharan & Craig A. Elmets. (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. Journal of the American Academy of Dermatology 80:4, pages 1029-1072.
Crossref
Eleftheria Tampouratzi, Theodora Kanni, John Katsantonis & Theodora Douvali. (2020) Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches. F1000Research 8, pages 2002.
Crossref
Eleftheria Tampouratzi, Theodora Kanni, John Katsantonis & Theodora Douvali. (2019) Case report: Treating a combination of hidradenitis suppurativa and psoriasis with different therapeutic approaches. F1000Research 8, pages 2002.
Crossref
Keiko Yamaguchi, Takaaki Hayashi, Genichiro Takahashi, Mami Momose, Akihiko Asahina & Tadashi Nakano. (2018) Successful Certolizumab Pegol Treatment of Chronic Anterior Uveitis Associated with Psoriasis Vulgaris. Case Reports in Ophthalmology 9:3, pages 499-503.
Crossref
Ricardo Ruiz-Villaverde, Carlos Cuenca-Barrales, Luis Salvador-Rodriguez & José Carlos Ruiz-Carrascosa. (2017) Certolizumab pegol, ¿un nuevo anti-TNF en el tratamiento de la psoriasis moderada-grave?. Piel 32:10, pages 644-649.
Crossref
Annunziata Dattola, Maria Vittoria Cannizzaro, Mauro Mazzeo & Luca Bianchi. (2017) Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data. Dermatology and Therapy 7:4, pages 485-492.
Crossref
Omid Roostaeyan, Dario Kivelevitch & Alan Menter. (2017) A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis. Immunotherapy 9:12, pages 963-978.
Crossref
Franziska Bootz & Dario Neri. (2016) Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions. Drug Discovery Today 21:1, pages 180-189.
Crossref
Maria Majdan, Anna Siwiec & Aleksandra Gryta. (2014) Certolizumab pegol – new option in the treatment of psoriatic arthritis. Rheumatology 52:3, pages 181-188.
Crossref
A. Armuzzi, P. Lionetti, C. Blandizzi, R. Caporali, S. Chimenti, L. Cimino, P. Gionchetti, G. Girolomoni, G. Lapadula, A. Marchesoni, A. Marcellusi, F.S. Mennini, C. Salvarani & R. Cimaz. (2016) Anti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on Adalimumab. International Journal of Immunopathology and Pharmacology 27:1_suppl, pages 11-32.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.